China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of Chinese medicine and pharmaceutical products in the People's Republic of China. The company offers granules, finished drugs, decoction pieces, and healthcare products. It is also involved in the plantation and management of Chinese medicinal herbs; manufacturing of traditional Chinese medicines (TCM); trading of pharmaceutical products; provision of TCM marketing, advertising, and consulting services; and retail of pharmaceuticals and decoction products. The company also provides property leasing services. It sells its products to hospitals and retail pharmacies. The company was formerly known as China Traditional Chinese Medicine Co. Limited and changed its name to China Traditional Chinese Medicine Holdings Co. Limited in July 2016. China Traditional China Traditional Chinese Medicine Holdings Co. Limited was founded in 1573 and is headquartered in Wan Chai, Hong Kong.
China Traditional Chinese Medicine Dividend Announcement
• China Traditional Chinese Medicine announced a annually dividend of HK$0.05 per ordinary share which will be made payable on 2023-06-20. Ex dividend date: 2023-06-02
• China Traditional Chinese Medicine annual dividend for 2023 was HK$0.05
• China Traditional Chinese Medicine's trailing twelve-month (TTM) dividend yield is -%
• China Traditional Chinese Medicine's dividend growth over the last five years (2018-2023) was -20.15% year
China Traditional Chinese Medicine Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2023-06-02 | HK$0.05 | annually | 2023-06-20 |
2022-06-29 | HK$0.07 | annually | 2022-07-29 |
2021-09-02 | HK$0.07 | annually | 2021-10-20 |
2020-06-24 | HK$0.05 | annually | 2020-07-13 |
2019-09-02 | HK$0.06 | annually | 2019-10-16 |
2019-06-06 | HK$0.06 | annually | 2019-06-28 |
2018-08-30 | HK$0.06 | annually | 2018-10-15 |
2018-06-15 | HK$0.05 | annually | |
2018-06-04 | HK$0.05 | annually | 2018-06-28 |
2017-10-11 | HK$0.05 | annually | 2017-10-26 |
2017-06-13 | HK$0.04 | annually | 2017-06-28 |
2016-09-15 | HK$0.06 | annually | |
2012-09-18 | HK$0.03 | annually | |
2012-05-15 | HK$0.05 | annually | |
2009-05-27 | HK$0.01 | annually | |
2008-05-16 | HK$0.01 | annually | |
2004-05-14 | HK$0.01 | annually |
China Traditional Chinese Medicine Dividend per year
China Traditional Chinese Medicine Dividend growth
China Traditional Chinese Medicine Dividend Yield
China Traditional Chinese Medicine current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing China Traditional Chinese Medicine stock? Use our calculator to estimate your expected dividend yield:
China Traditional Chinese Medicine Financial Ratios
China Traditional Chinese Medicine Dividend FAQ
Other factors to consider when evaluating China Traditional Chinese Medicine as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy China Traditional Chinese Medicine stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: China Traditional Chinese Medicine's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, China Traditional Chinese Medicine publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, China Traditional Chinese Medicine distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from China Traditional Chinese Medicine are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: China Traditional Chinese Medicine sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, China Traditional Chinese Medicine distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: China Traditional Chinese Medicine declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of China Traditional Chinese Medicine's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review China Traditional Chinese Medicine's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.